Live Breaking News & Updates on Normal Gene

Stay updated with breaking news from Normal gene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the American Society of Gene & Cell Therapy has accepted 20 Sangamo abstracts for presentation at the 27th ASGCT Annual. ....

Kamy Pooler , Greg Davis , American Society Of Gene Cell Therapy , Development Of Blood , Head Of Research At Sangamo , Development Of Modular Integrases Mints , Head Of Technology At Sangamo , Sangamo Therapeutics Inc , Formulation Development , Exchange Commission , Sangamo Therapeutics , American Society , Cell Therapy , Modular Integrases , Dravet Syndrome , Meeting Presentations , Central Nervous , Normal Gene , Protein Expression , Human Disease Models , Haploinsufficiency Using Zinc Finger Activators , Zinc Finger Activator Platform , Restore Normal Gene , Cellular Models , Repression Mediated , Zinc Finger Repressors ,